We are live on ! Find out more

2,651 hedge funds and large institutions have $139B invested in Merck in 2021 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 1,242 increasing their positions, 979 reducing their positions, and 101 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $2.93B | Put options by funds: $1.72B

27% more repeat investments, than reductions

Existing positions increased: 1,242 | Existing positions reduced: 979

13% more first-time investments, than exits

New positions opened: 114 | Existing positions closed: 101

4% more funds holding in top 10

Funds holding in top 10: 81 → 84 (+3)

0.42% less ownership

Funds ownership: 73.38% → 72.96% (-0.42%)

1% less funds holding

Funds holding: 2,676 → 2,651 (-25)

9% less capital inflows, than outflows

Capital inflows: $5.43B | Capital outflows: $6B

Holders
2,651
Holders Change
-25
Holders Change %
-0.93%
% of All Funds
46.24%
Holding in Top 10
84
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+3.7%
% of All Funds
1.47%
New
114
Increased
1,242
Reduced
979
Closed
101
Calls
$2.93​B
Puts
$1.72​B
Net Calls
+$1.22​B
Net Calls Change
+$893​M

MRK Hedge Fund Activity: Q3 2021 in Review

2,651 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2021, worth a combined $139B — down 3.8% from $144B a quarter earlier.

Buyers outnumbered sellers: 114 funds opened new MRK positions and 101 closed out — a net gain of 13 holders — while 1,242 added to existing stakes and 979 trimmed.

The largest buyer was Invesco, adding an estimated $433M. The largest seller was Vanguard Group, cutting an estimated $1.15B.

  • 2,651 institutional investors held Merck (MRK) as of Q3 2021, down from 2,676 in Q2 2021.
  • Funds reported $139B of Merck stock for Q3 2021, down 3.8% quarter-over-quarter.
  • 114 funds opened new Merck positions in Q3 2021 and 101 closed out, a net change of +13 holders.
  • The largest Merck buyer in Q3 2021 was Invesco, an estimated $433M added.
  • The largest Merck seller in Q3 2021 was Vanguard Group, an estimated $1.15B sold.

Based on aggregated 13F filings for Q3 2021.